PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.15%
R&D change of 35.15% versus flat Healthcare spending. Walter Schloss would verify adequacy.
3110.63%
G&A change of 3110.63% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11227.11%
Operating expenses change of 11227.11% versus flat Healthcare costs. Walter Schloss would verify control.
11227.11%
Total costs growth exceeding 1.5x Healthcare median of 0.10%. Jim Chanos would check for waste.
26362.71%
Interest expense change of 26362.71% versus flat Healthcare costs. Walter Schloss would verify control.
-84.19%
D&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency.
-40.83%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-9873.13%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-850.18%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-16129.65%
Pre-tax income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
155593.20%
Tax expense change of 155593.20% versus flat Healthcare. Walter Schloss would verify strategy.
-16129.65%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-12933.18%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-12933.18%
Diluted EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
24.22%
Share count change of 24.22% versus stable Healthcare. Walter Schloss would verify approach.
24.22%
Diluted share change of 24.22% versus stable Healthcare. Walter Schloss would verify approach.